(Q38019839)

27 August 2017

title

Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults (English)

1 reference

27 August 2017

0 references

Manjunath P Pai

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

18 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

32

1 reference

27 August 2017

issue

9

1 reference

27 August 2017

page(s)

856-868

1 reference

Estimating the glomerular filtration rate in obese adult patients for drug dosing.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Quantification of lean bodyweight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Simplified calculation of body-surface area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

What is the best size descriptor to use for pharmacokinetic studies in the obese?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

The effects of obesity on drug pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Implications of obesity for drug therapy: limitations and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Human organ/tissue growth algorithms that include obese individuals and black/white population organ weight similarities from autopsy data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

The origin of the 1 x 73-m2 body surface area normalization: problems and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Anthropometric variability in the USA: 1971-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

The mysterious trend in American heights in the 20th century

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Progress in genome-wide association studies of human height.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Adolphe Quetelet (1796-1874)--the average man and indices of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Development of predictive equations for body density of sumo wrestlers using B-mode ultrasound for the determination of subcutaneous fat thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Assessment methods in human body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Theoretical versus empirical allometry: Facts behind theories and application to pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Lysergic Acid Diethylamide: Its Effects on a Male Asiatic Elephant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Extrapolation of animal toxicity data to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Curvature in metabolic scaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Physiology: There is no single p.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Informative study designs to identify true parameter-covariate relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Analytic theories of allometric scaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

The fourth dimension of life: fractal geometry and allometric scaling of organisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Is fractal geometry useful in medicine and biomedical sciences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

The origin of the "ideal" body weight equations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Body composition phenotypes in pathways to obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Adverse renal consequences of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Allometric scaling of xenobiotic clearance: uncertainty versus universality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Allometric scaling of clearance in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net reabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

How to calculate the dose of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Dose calculation of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Colistin dosing and nephrotoxicity in a large community teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Population pharmacokinetics of daptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Age and sex effects on the pharmacokinetics of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Population pharmacokinetics of linezolid in patients treated in a compassionate-use program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01108.X

10.1002/J.1875-9114.2012.01108.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference